NASDAQ · Biotechnology

Lycia Therapeutics, Inc. (LYCA) Stock

$30.00 +66.67% NASDAQ: LYCA Healthcare

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company.

Valuation

Metric	Value
Price	$30.00
Market Cap	$1.56B
P/E Ratio	—
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	—
52-Week High	$36.49
52-Week Low	$22.19
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	—
Operating Margin	—
Net Margin	—
Debt/Equity	—
Current Ratio	—

Latest News

Lycia Therapeutics surges in debut following upsized $317.5M IPO Investing.com · Oct 23, 2026

About Lycia Therapeutics, Inc.

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.

Lycia Therapeutics, Inc. is headquartered in US.

Lycia Therapeutics, Inc. (LYCA) stock trades at $30.00 with a market capitalization of $1.56B. Over the past 52 weeks the stock has ranged between $22.19 and $36.49, and currently trades 17.8% below its 52-week high.

Official website: lyciatx.com

Lycia Therapeutics, Inc. (LYCA) — frequently asked questions

What is Lycia Therapeutics, Inc. (LYCA) stock price today?

Lycia Therapeutics, Inc. (LYCA) is currently trading at $30.00, up 66.67% today.

What is Lycia Therapeutics, Inc.'s market cap?

Lycia Therapeutics, Inc. has a market capitalization of $1.56B.

What sector is LYCA in?

Lycia Therapeutics, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is LYCA listed on?

Lycia Therapeutics, Inc. trades on NASDAQ under the ticker LYCA.

What is LYCA's 52-week range?

Over the last year Lycia Therapeutics, Inc. has traded between $22.19 and $36.49.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Screens LYCA currently matches

On the figures above, Lycia Therapeutics, Inc. passes the filters for 4 of our ready-made screens, among them Day Gainers Stocks, Small Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Day Gainers Stocks Small Cap Stocks Stocks Under $100 Stocks Under $50

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.